Another 6.6 million Americans — including more than 270,000 in D.C., Maryland and Virginia — filed initial U.S. unemployment claims last week, extending the economic crisis related to the coronavirus pandemic.
Details the CEO buys for the following companies: GEO Group, Bunge, Magnolia Oil & Gas, American Assets Trust and Inovalon Holdings Continue reading...
Q1 2020 Inovalon Holdings Inc Earnings Call
Inovalon (INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced that it has launched a telehealth configuration of the Inovalon ONE® Platform, empowering virtual data-driven visits with clinicians for clients across the country. The implementation of telehealth capabilities within Inovalon ONE® Platform brings the power of advanced analytics and data-driven encounters to the telehealth marketplace.
This is Kim Collins, senior vice president of communications at Inovalon. The press release announcing our financial results for the first quarter of 2020 was distributed this afternoon, and a replay of today's call will be available shortly, posted on the investor relations page on Inovalon's website.
First Quarter 2020 Highlights Q1 revenue of $154.2 million, up 6.0% year-over-yearQ1 Subscription-based platform revenue of $137.1 million, up 13.1% year-over-year, equating to.
Inovalon Holdings (INOV) delivered earnings and revenue surprises of 0.00% and -2.71%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Statistically speaking, long term investing is a profitable endeavour. But along the way some stocks are going to...
ABILITY® Network, an Inovalon company (INOV) a leading provider of cloud-based platforms empowering data-driven healthcare, today announced a collaboration agreement with PracticeSuite, a cloud-based healthcare technology solution and service provider for independent practices, to improve the efficiency and accuracy of payer claims management. The ABILITY EASE® All-Payer solution, a cloud-based application available through the ABILITY provider platform modules of the Inovalon ONE® Platform, is now accessible to the more than 57,000 medical professionals served by PracticeSuite.
BOWIE, Md., May 19, 2020 -- Inovalon (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced the availability of its new.
BOWIE, Md., April 15, 2020 -- Inovalon (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced that it will hold a.
BOWIE, Md., May 27, 2020 -- Inovalon (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, announced today the launch of.
Today we are going to look at Inovalon Holdings, Inc. (NASDAQ:INOV) to see whether it might be an attractive...
BOWIE, Md., May 18, 2020 -- Inovalon (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced that Keith Dunleavy, M.D.,.
BOWIE, Md., March 03, 2020 -- Inovalon (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced that Keith Dunleavy, M.D.,.
Inovalon Holdings (INOV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Inovalon (INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced the launch of its Consumer Health Gateway™, a Fast Healthcare Interoperability Resources (FHIR®)-based solution Module of the Inovalon ONE® Platform that enables health plans with Medicare Advantage, Commercial ACA and Medicaid/CHIP insurance products to easily and efficiently comply with the new Patient Access Application Program Interface (API) requirement of the 21st Century Cures Act, effective July 1, 2021, while also paving the way for applications empowering consumers to access and benefit from their own personal healthcare data in real time. Under the 21st Century Cures Act, organizations engaged in supporting and providing care within the United States are required to support increasing interoperability and access to patient-level data as the Centers for Medicare and Medicaid (CMS) focuses on empowering improved quality and efficiency of patient care.
Avalere, an Inovalon company specializing in healthcare research and strategic advisory services, has entered into a collaboration with Corrona, a leader in real-world evidence generation in autoimmune diseases through its independent registry platform. Under the agreement, Avalere will utilize data from Inovalon's large scale, real-world MORE2 Registry® dataset along with data elements from Corrona's clinical registries. The MORE2 Registry® dataset contains primary source, de-identified, and longitudinally matched medical, pharmacy, and laboratory data on more than 314 million unique patients spanning 53 billion medical events and more than 988,000 physicians across Medicare, Medicaid, and commercially insured markets. Corrona collects deep clinical data on validated physician assessments used in pivotal phase 3 trials as well as disease-specific patient reported outcomes, yielding a comprehensive longitudinal dataset that stands apart from datasets derived from electronic medical records, claims, or patient surveys. Data collected from over 500 sites in the US, Canada, and Japan make Corrona the largest network of real-world investigators contributing prospective data for patients with autoimmune conditions. Combined, the datasets will offer a complete and highly differentiated picture of patients with autoimmune conditions, enabling the real-world and longitudinal assessment of the dynamics between patient demographics, clinical characteristics, functional status, patient-reported outcome measures, laboratory values, healthcare resource utilization, and economic outcomes.
Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Inovalon Holdings, Inc. New York, May 27, 2020 -- Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Inovalon Holdings, Inc. and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers.
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]